2016-05-18 15:56:23 UTC

AGA Perspectives Features Elastography Debate

May 18, 2016

Drs. Stuart Gordon and Keyur Patel present an overview of elastography technology for HCV patients.

The new, April/May issue of AGA Perspectives is now available online, featuring a debate about elastography technology for testing liver stiffness in HCV patients. Other articles in the latest magazine edition cover a broad range of GI-focused topics, including chronic cough, the microbiome and health maintenance measures for IBD patients. 

In the featured articles, Stuart Gordon, MD, advocates for the growing adoption of the technology, while Keyur Patel, MD, points to the potential drawbacks that relying on the technology could have compared to other diagnostic methods, such as liver biopsy.

This issue provides a number of articles on the future generations of GIs. Siddharth Singh, MD, and Renumathy Dhanasekaran, MD, provide readers an inside look at the AGA Young Delegates program, Brijen Shah, MD, discusses the importance of health policy in medical education, and Shounak Majumder, MBBS, MD, provides the perspective of an international trainee in the U.S.

To read these articles and more, visit agaperspectives.gastro.org

More on Barrett's Esophagus

Porcine Esophageal Submucosal Gland Culture Model Shows Capacity for Proliferation and Differentiation

Oct. 22, 2017

We describe a novel porcine 3-dimensional culture model that reproduces esophageal submucosal gland proliferation in vivo associated with cancer and injury.

Late Recurrence of Barrett’s Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial

Sept. 1, 2017

Endoscopic surveillance of patients with BE treated with radiofrequency ablation will likely be of diminishing value as the time since ablation grows.

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device

Sept. 1, 2017

We found Cytosponge screening with endoscopic confirmation to be a cost-effective strategy.